We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Herpes Viruses Sabotage Histocompatibility Complex

By Biotechdaily staff writers
Posted on 27 Jan 2003
A recent study has found that herpes viruses avoid destruction by the immune system through a mechanism that interferes with the expression of molecules of the major histocompatibility complex (MHC) on the surface of cells. More...
The study was published in the January 2003 issue of Immunity.

Researchers from Washington University School of Medicine (St. Louis, MO, USA) found that the viral mK3 protein acted as a pseudo-chaperone molecule during the assembly of MHC class I molecules by the TAP/tapasin complex.

Tapasin is a transmembrane glycoprotein located in the endoplasmic reticulum that plays an important role in the assembly and peptide binding process of the MHC class I molecule. Tapasin is a subunit of the protein complex consisting of the transporter associated with antigen processing (TAP), MHC class I, and the chaperone molecule calreticulin. Tapasin binds to TAP1 and to beta-2 microglobulin (after beta-2 m has bound the MHC I alpha chain), thus acting as a bridge between the MHC I molecule and the TAP1/2 complex.

The viral mK3 protein joined the TAP/tapasin complex as a pseudo-chaperone molecule and labeled the MHC I molecule with ubiquitin, which marked it for destruction by cellular proteasomes. The destruction of the MHC molecule prevented expression of viral antigens on the cell surface and prevented the immune system from recognizing the herpes virus.

"These findings not only provide a better understanding of viral infections,” explained senior author Dr. Ted H. Hansen, professor of genetics at Washington University School of Medicine. "They also offer novel insights into basic cellular processes in the immune system.”



Related Links:
Washington University School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.